Current clinical data showed low percentages of GLUT2+CD45RO+ PB-IPC in prediabetic, recent onset, and longstanding T1D patients, which indicates the novel mechanism involved in the pathogenesis of T1D. Here, SLC2A2 is linked to type 1 diabetes mellitus.